CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-28 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +21,682 | 124,975.51 | ||
| 2021-02-28 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −21,682 | 65,048 | ||
| 2021-02-28 | Drape Eric Executive VP Global Operations | Option exercise | +19,514 | 59,086 | ||
| 2021-02-28 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −19,514 | 58,543 | ||
| 2021-02-28 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +17,346 | 76,749.7 | ||
| 2021-02-28 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −17,346 | 52,038 | ||
| 2021-02-28 | Daniell Richard Exec. VP, European Commercial | Option exercise | +20,598 | 31,363 | ||
| 2021-02-28 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −20,598 | 61,795 | ||
| 2021-02-16 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −3,926 | $11.12 | $44K | 2,974.39 |
| 2021-02-16 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −2,098 | $11.12 | $23K | 103,293.51 |
| 2021-02-16 | Drape Eric Executive VP Global Operations | Sale | −2,079 | $11.13 | $23K | 39,572 |
| 2021-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +3,926 | 6,900.39 | ||
| 2021-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −3,926 | 0 | ||
| 2021-02-14 | Sabag Mark See "Remarks" below | Option exercise | +5,712 | 111,324 | ||
| 2021-02-14 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −5,712 | 0 | ||
| 2021-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +5,355 | 105,391.51 | ||
| 2021-02-14 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −5,355 | 0 | ||
| 2021-02-14 | Drape Eric Executive VP Global Operations | Option exercise | +3,926 | 41,651 | ||
| 2021-02-14 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −3,926 | 0 | ||
| 2021-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +12,538 | 15,512.39 |
Page 50 of 76 · 1,517 trades